Cargando…
‘No evidence of disease activity’ – is it an appropriate surrogate in multiple sclerosis?
The increasing number of disease‐modifying treatments available for multiple sclerosis has broadened treatment options for patients, but also challenges clinicians to select the best therapy for each individual at the appropriate stage of the disease. Early prediction of treatment response still rem...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099351/ https://www.ncbi.nlm.nih.gov/pubmed/29687559 http://dx.doi.org/10.1111/ene.13669 |